Dongwon F&B selects virtual human family as brand model

South Korea's food and beverage company Dongwon F&B Co. announced on Friday that it has selected a virtual human family as the model for its pre...

LegoChem Bio receives FDA approval for phase 1,2 trials of LCB84

South Korean pharmaceutical firm LegoChem Biosciences Inc. announced on Thursday that it has received approval from the US Food and Drug Administrat...

Celltrion wins phase 3 IND approval for Ocrevus biosimilar in US

South Korea's biopharmaceutical company Celltrion Inc. announced that it received on Thursday approval from the US Food and Drug Administration (FDA...

Hanmi Pharm's Efinopegdutide gets Fast Track Designation from FDA

Merck, known as MSD outside the United States and Canada, announced on Monday that Efinopegdutide, a technology transferred from the South Korean ph...

Celltrion unveils phase 1 clinical data of Actemra biosimilar in Europe

South Korean biosimilar giant Celltrion Inc. revealed on Wednesday the highly anticipated clinical phase 1 data for its Actemra biosimilar, CT-P47, ...

Cellid applies for Phase 3 clinical trials in S.Korea for COVID-19 vaccine

South Korean bio-venture Cellid Co. announced on Tuesday that it has applied for the clinical Phase 3 trial of the COVID-19 Omicron variant-specific...

Virtual human YT debuts as SSG.COM’s shopping host

SSG.COM, the e-commerce brand of South Korean retail giant Shinsegae Inc., announced on Tuesday that virtual human YT has been named the official sh...

S.Korea's Bertis releases two academic findings at AOHUPO conference

Bertis, South Korean company specializing in the development of proteomics-based precision medicine technology, announced on Monday that it presente...

Hyosung’s sibling feud continues with second son in court on trial

It all began in July 2014 when Cho Hyun-joon, currently the Hyosung Group chairman, was sued by his younger brother Cho Hyun-moon on charges of embe...

Celltrion applies for Phase 3 clinical trials in Europe for biosimilar

South Korea’s Celltrion Inc. is speeding up global clinical trials of its biosimilar of the multiple sclerosis (MS) treatment Ocrevus (active ...

SK Telecom, Golfzon develop AI golf platform

An artificial intelligence platform in South Korea has produced a golfing coach that analyzes and diagnoses problems in swing posture and recommends...

HYBE bets big on AI; to unveil generative AI project in May: Chairman Bang

HYBE Co. is set to wow the world again but this time with the much-hyped generative artificial intelligence technology as it plans to unveil an unpr...

CG Bio establishes US corporation to develop tissue products

South Korean bio-regenerative medical firm CG Bio has launched a new US corporation CG MedTech, to focus on the development and marketing of tissue ...

Samsung faces $303 mn jury verdict in memory patent lawsuit in US

Samsung Electronics Co. lost a semiconductor patent infringement lawsuit filed in the US. The South Korean company received a jury verdict to pay ab...

AbClon shows promising results in clinical tests of leukemia treatment

South Korean companies are standing out in the global competition to develop chimeric antigen receptor T-cell (CAR-T) treatments, dubbed "dream" a...

Vaxcell-bio's NK cell therapy wins therapeutic approval for liver cancer

South Korean anti-cancer immunotherapy company Vaxcell-Bio Therapeutics announced on Friday that its natural killer (NK) cell therapy, Vax-NK/HCC, h...

HLB starts Phase 3 clinical trials for ophthalmic disease treatment in US

South Korea's pharmaceutical company HLB Therapeutics Co. announced on Thursday that it has started patient administration of "RGN-259," a treatment...

JW Pharma to use zebrafish in new drug development

South Korean drug developer JW Pharmaceutical has entered into a memorandum of understanding (MOU) with Zefit, a domestic non-clinical trial institu...

HLB Cell develops organoid biomaterial based on human normal cells

HLB Cell, a subsidiary of HLB Life Science Co., which specializes in the development of cell therapy products, announced on April 4 that it succeede...

S.Korea's Elice, FuriosaAI to develop training for AI semiconductor talent

South Korea's artificial intelligence (AI) digital education provider Elice on Tuesday said it signed a memorandum of understanding with the AI semi...

S.Korean startup DeepBrain AI unveils 3D virtual human B2B technology

South Korean AI startup DeepBrain AI has unveiled a 3D virtual human B2B technology that can engage in real-time conversations, display emotional ex...

Boryung, Axiom Space to set up JV to explore space healthcare options

South Korea's Boryung Corp., just decades ago a mom-and-pop pharmacy, will bring its healthcare expertise to space with Axiom Space Inc., a US comme...

Korea's LG CNS launches cloud cost optimization service

LG CNS, a South Korean company specializing in digital transformation, announced on Tuesday the launch of its new service called "FinOps" Clinic.Fin...

S.Korea's FutureChem gets approval for phase 3 clinical trials in China

South Korean radiopharmaceutical development company FutureChem Co. announced on Thursday that China's National Medical Products Administration (NMP...

Prestige Bio's pancreatic cancer treatment gets US FDA fast-track designation

Prestige Biopharma, a biopharmaceutical company in South Korea, announced on Thursday that their pancreatic cancer antibody drug, PBP1510 (Ulenistam...

S.Korean biotech NKMax’s unit aims for US IPO

NKMax Co., a South Korean cancer drug maker, is in talks with local and foreign investors in a bid to list its California-based unit NKGen Biotech I...

CGBio opens cosmetic surgery clinic in Bali using bio-medical tech

CGBio, a South Korean bio-renewable medical company, announced on Monday that it opened a medical esthetic clinic, called Nulook, in Bali, Indonesia...

OliX's hair loss treatment candidate approved for clinical trial in Australia

South Korea's OliX Pharmaceuticals has received approval from Australia's Human Research Ethics Committees (HREC) to plan a phase 1 clinical trial o...

GC Biopharma to develop mRNA flu vaccine with Canadian pharma

South Korea's GC Biopharma Corp. announced on Thursday that it will start developing a flu vaccine based on messenger ribonucleic acid (mRNA).The dr...

SK Networks invests $22 mn in US AI-based device company

South Korea's SK Networks has identified a startup specializing in AI-based devices and software platforms as a new investment target. The startup, ...